STOCK TITAN

Humana (HUM) legal chief awarded 10,318 shares plus option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Humana Inc. Chief Legal Officer Joseph C. Ventura received 10,318 shares of Humana Common stock as a grant on May 1, 2026, at $0.00 per share, bringing his direct holdings to 27,405 shares.

He also holds 294 Humana Common shares indirectly through a retirement savings plan. In addition, he retains several option awards on Humana Common stock with exercise prices between $350.7875 and $510.2425 per share, expiring from 2027 through 2031.

Positive

  • None.

Negative

  • None.
Insider Ventura Joseph C
Role Chief Legal Officer
Type Security Shares Price Value
Grant/Award Humana Common 10,318 $0.00 --
holding Options -- -- --
holding Options -- -- --
holding Options -- -- --
holding Options -- -- --
holding Options -- -- --
holding Humana Common -- -- --
Holdings After Transaction: Humana Common — 27,405 shares (Direct, null); Options — 4,656 shares (Direct, null); Humana Common — 294 shares (Indirect, See Footnote)
Footnotes (1)
  1. Shares held for the benefit of reporting person as of April 30, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Includes 16,568 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan and 2026 Stock Incentive Plans.
Stock grant 10,318 shares Humana Common Awarded May 1, 2026 at $0.00 per share
Direct common shares after grant 27,405 shares Humana Common held directly following the reported award
Indirect plan holdings 294 shares Humana Common in Retirement Savings Plan as of April 30, 2026
Option grant 1 $367.2100 exercise price Options on Humana Common expiring February 21, 2031, 6,572 underlying shares
Option grant 2 $510.2425 exercise price Options on Humana Common expiring February 24, 2030, 4,162 underlying shares
Option grant 3 $425.0550 exercise price Options on Humana Common expiring February 21, 2029, 3,932 underlying shares
restricted stock units financial
"Includes 16,568 restricted stock units representing a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Tax-Conditioned Plan financial
"a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan"
Rule 16b-3 regulatory
"exempt under Rule 16b-3(c)"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
2019 Amended & Restated Stock Incentive Plan financial
"pursuant to Company's 2019 Amended & Restated Stock Incentive Plan"
stock options financial
"Incentive and Non-Qualified stock options granted to reporting person"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ventura Joseph C

(Last)(First)(Middle)
HUMANA INC.
101 E. MAIN STREET

(Street)
LOUISVILLE KENTUCKY 40202

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Humana Common05/01/2026A10,318A$027,405(7)D
Humana Common294ISee Footnote(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options(2)$350.7875 (2)02/24/2027Humana Common4,6564,656D
Options(3)$376.61 (3)02/22/2028Humana Common4,5984,598D
Options(4)$425.055 (4)02/21/2029Humana Common3,9323,932D
Options(5)$510.2425 (5)02/24/2030Humana Common4,1624,162D
Options(6)$367.21 (6)02/21/2031Humana Common6,5726,572D
Explanation of Responses:
1. Shares held for the benefit of reporting person as of April 30, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
3. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
4. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
5. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
6. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
7. Includes 16,568 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan and 2026 Stock Incentive Plans.
Joseph C. Ventura05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Humana (HUM) executive Joseph C. Ventura report in this Form 4?

Joseph C. Ventura reported receiving a stock grant and updating his holdings. He was awarded 10,318 shares of Humana Common on May 1, 2026, raising his direct holdings to 27,405 shares and disclosing additional indirect shares and outstanding stock options.

How many Humana (HUM) shares did Joseph C. Ventura acquire in this filing?

He acquired 10,318 shares of Humana Common stock as a grant. The award was reported at a price of $0.00 per share and increased his directly held Humana Common shares to 27,405 after the transaction described in this Form 4 filing.

What are Joseph C. Ventura’s total Humana (HUM) common share holdings after the grant?

After the grant, Ventura directly holds 27,405 Humana Common shares. He also has 294 additional Humana Common shares held indirectly in a retirement savings plan for his benefit, reflecting routine payroll deductions, dividend allocations, and fee-related share dispositions noted in the footnotes.

What stock options on Humana (HUM) does Joseph C. Ventura hold according to this filing?

Ventura holds several option awards on Humana Common stock with different exercise prices and maturities. Examples include options with a $367.2100 exercise price expiring February 21, 2031, and options at $350.7875 expiring February 24, 2027, all granted under Humana’s stock incentive plans.

Are the reported Humana (HUM) transactions open-market purchases or compensation grants?

The primary transaction is a compensation-related stock grant, not an open-market purchase. The 10,318 Humana Common shares were awarded at $0.00 per share, consistent with equity compensation, and the filing does not show any open-market buy or sell transactions.

What restricted stock units does Joseph C. Ventura hold in Humana (HUM)?

A footnote states that Ventura’s holdings include 16,568 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock under the company’s 2019 Amended & Restated Plan and 2026 Stock Incentive Plans.